Obesity and Allometric Scaling of Pharmacokinetics
- 1 November 2011
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 50 (11), 751-753
- https://doi.org/10.2165/11594080-000000000-00000
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Population Pharmacokinetics and Pharmacodynamics of Propofol in Morbidly Obese PatientsClinical Pharmacokinetics, 2011
- Lean Body Weight Scalar for the Anesthetic Induction Dose of Propofol in Morbidly Obese SubjectsAnesthesia & Analgesia, 2011
- Perioperative pharmacology in morbid obesityCurrent Opinion In Anesthesiology, 2010
- Comparative evaluation of propofol 350 and 200 mg for induction of anaesthesia in morbidly obese patients: a randomized double-blind pilot studyEuropean Journal of Anaesthesiology, 2010
- Prediction of Propofol Clearance in Children from an Allometric Model Developed in Rats, Children and Adults versus a 0.75 Fixed-Exponent Allometric ModelClinical Pharmacokinetics, 2010
- Effect of Obesity on the Pharmacokinetics of Drugs in HumansClinical Pharmacokinetics, 2010
- Pharmacokinetic Model-Driven Remifentanil Administration in the Morbidly ObeseClinical Pharmacokinetics, 2009
- Total intravenous anaesthesia to obese patients: largely guesswork?European Journal of Anaesthesiology, 2009
- No adjustment vs. adjustment formula as input weight for propofol target-controlled infusion in morbidly obese patientsEuropean Journal of Anaesthesiology, 2009
- Propofol Infusion for Maintenance of Anesthesia in Morbidly Obese Patients Receiving Nitrous Oxide A Clinical and Pharmacokinetic StudyAnesthesiology, 1993